`The appropriate administrative and programmatic staff of any organisation participating in this grant application shall be known to the NIHL consortium agreement`s research agreement shall be implemented by the beneficiary and one or more other entities which are separate legal persons. Under the agreement, the beneficiary must play an essential role in carrying out the proposed research and not only serve as a channel of money for another party or party. These agreements typically include a specific charge from the unionized organization`s PD/IP and a categorical breakdown of costs, such as personnel, accessories, and other eligible expenses, including R&A costs. The relationship between the beneficiary and the cooperating organisations shall be considered a subordinate relationship. (See chapter Consortium agreements in IIB). and are ready to conclude the necessary inter-organizational agreements in accordance with this policy. The following information must be provided to NIH as part of a competing application that proposes consortium agreements: It is appropriate for the syndicated site to be designated as the consortium`s lead auditor responsible for the proper execution of the project or program at the consortium site. However, the PD/IP role should only be assigned to this person if a multiple PD/IP application is filed. Otherwise, this person should be assigned a different project role within senior/key staffDPs/PPs and other persons who contribute substantially and measurably to the scientific development or implementation of a project, whether or not they receive salaries or allowances under the grant. . . .